Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05273801 · ClinicalTrials.gov registry record · NA

Assessing Visual Feedback of HR Monitoring in Rehabilitation - Pilot

A NA study, sponsored by Shirley Ryan AbilityLab.

Completed
Registry status
NA
Development phase
18
Enrollment target

NCT05273801: Completed NA study, sponsored by Shirley Ryan AbilityLab.

NCT05273801 is a NA study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05273801, a NA study, has completed, sponsored by Shirley Ryan AbilityLab.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

Monitoring heart rate during exercise can provide feedback to the patient and provider that the patient is exercising in the appropriate, individualized and safe range for them. This is particularly important in a group setting when multiple individuals are supervised by one provider. This study is interested in assessing the difference in intensity of care delivered when visual feedback of heart rate is provided compared to no visual feedback of heart rate in rehabilitation. Visual feedback of heart rate will be provided through Heart Zones, a platform which synthesizes multiple signals from externally worn heart rate monitors. This study is interested in better understanding the acceptability, feasibility and appropriateness of this technology when used in rehabilitation.

Primary Outcome

Number of times heart rate (beats/minute), Rate of perceived exertion (6-20, higher = greater perceived exertion) or intensity (asked in session by HR/RPE) is monitored and/or modified based on feedback during rehabilitation sessions.

Interventions

  • DEVICE Heart Rate Recording from Multiple Participants, No Visual Feedback
  • DEVICE Visual Feedback of Multiple Participant Heart Rates

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2022-01-28
Est. Completion 2022-05-01
Phase NA
Shirley Ryan AbilityLab

138 total trials

What the finished NCT05273801 record still lists

NCT05273801 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Heart Rate Recording from Multiple Participants, No Visual Feedback is the first listed.

NCT05273801 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05273801 about?

NCT05273801 is a clinical study titled "Assessing Visual Feedback of HR Monitoring in Rehabilitation - Pilot". Monitoring heart rate during exercise can provide feedback to the patient and provider that the patient is exercising in the appropriate, individualized and safe range for them. This is particularly important in a group setting when multiple individuals are supervised by one provider. This study is ...

What is the current status of trial NCT05273801?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2022-01-28. Estimated completion is 2022-05-01.

What interventions are being tested in trial NCT05273801?

The interventions under investigation include: Heart Rate Recording from Multiple Participants, No Visual Feedback (DEVICE), Visual Feedback of Multiple Participant Heart Rates (DEVICE).

Who is sponsoring clinical trial NCT05273801?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05273801's enrollment target sits among peer trials

18 1863rd of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05273801, the US trial registry maintained by the National Library of Medicine. NCT05273801 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.